Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

TBTC Study 27: Moxifloxacin vs Ethambutol for TB Treatment

This study has been completed.
Sponsor:
Information provided by:
Centers for Disease Control and Prevention
ClinicalTrials.gov Identifier:
NCT00140309
First received: August 30, 2005
Last updated: March 16, 2007
Last verified: March 2007